TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL
Chinese PLA General Hospital
Chinese PLA General Hospital
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ossium Health, Inc.
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
Princess Maxima Center for Pediatric Oncology
M.D. Anderson Cancer Center
Chinese PLA General Hospital
M.D. Anderson Cancer Center
City of Hope Medical Center
Instituto Nacional de Cancer, Brazil
Hoffmann-La Roche
Celgene
University Hospital Heidelberg
Columbia University
Indiana University
M.D. Anderson Cancer Center
TCR2 Therapeutics
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
National Cancer Institute (NCI)
Therapeutic Advances in Childhood Leukemia Consortium
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sanofi
University of Kentucky
M.D. Anderson Cancer Center
Northwestern University